CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia	Bacterial Infections and Mycoses, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pneumocystis infectious disease, Pneumocystis jirovecii Infection, Respiration Disorders, Respiratory Aspiration, fungal infectious disease, fungal lung infectious disease, interstitial lung disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder	Recruiting	Phase 1 / Phase 2	2026-10-09		NCT06892951

28 results · Page 1 of 2

Swipe the table sideways for more columns.

Organizations	Linked trials
Aerogen	6
Amiens University Hospital	7
Cape Cod Incorporated	1
Centre Hospitalier Universitaire de Besancon	73
Centre Hospitalier Universitaire de Nice	229
Centre Hospitalier Universitaire Dijon	130
Henri Mondor University Hospital	19
Hopital Foch	23
Hospices Civils de Lyon	429
Hospital Avicenne	8
Hôpital Necker-Enfants Malades	15
Institut National de la Santé Et de la Recherche Médicale, France	219
Nantes University Hospital	223
Ohre Pharma	1
Pitié-Salpêtrière Hospital	13
Poitiers University Hospital	76
Reims University hospital	4
Rennes University Hospital	89
Tours university	3
University Hospital, Angers	123
University Hospital, Bordeaux	221
University Hospital, Brest	146
University Hospital, Grenoble	183
University Hospital, Lille	194
University Hospital, Limoges	60

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
CHRU Tours	Tours	France	18
CHU Orléans	Orléans	France	11
CHU Tours	Tours	France	20

Clinical trials